InsidersTradesSigma
Follow the IRLAB Therapeutics AB (publ) share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Market capitalisation: €265.9m. The latest transaction was filed on 28 July 2026 (Purchase). Among the most active insiders: Jan-Fredrik Wilhelm Backman. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IRLAB Therapeutics AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).